Separate names with a comma.
The 50% surge in the last 3 months brought the stock price back up to the levels from over a year ago. The bulls are stoked about Pandora’s...
A few days ago, Ripple released somewhat disappointing figures for Q2'18. Ripple holds a vast amount of the total supply of XRP in an escrow...
Caterpillar increased manufacturing segment revenue 33% to $12.2 billion compared with the prior year’s quarter. The industry has been in growth...
AAPL enjoys stellar returns on its devices by offering a unique user experience with its iOS ecosystem. Contrary to its peers in PCs and...
Sitting on a cash pile of over CNY 100 billion, Baidu has ample dry powder to invest in technology, particularly in artificial intelligence, as...
Ethereum Classic touts decentralization and transparency as its strong points--and SEC made a verdict the altcoin is not a security. This leaves...
Exxon is the highest-quality integrated oil overall (operating and assets) and that its downstream and chemicals segments are key differentiators....
Aided by almost 400 million estimated global active users, more than 100 million Prime members, and recent fulfillment infrastructure, technology,...
As cloud computing continues to garner significant investment, Intel's data center group will be an indirect beneficiary. The Altera acquisition...
Bitcoin's dominance in the crypto market got a boost when its price broke the $8,000 level for the first time in the past two months. This sudden...
Facebook is also applying artificial intelligence and virtual and augmented reality technologies to various products, which may increase Facebook...
Piper Jaffray is upbeat on the optical-equipment makers today, as the firm sees easier comparables amid a reset at China's ZTE, now working free...
The candidate has the potential advantage of becoming the first FDA-approved drug for Hemophilia B patients as a prophylactic subcutaneous...
Analysts expect Qualcomm’s licensing business to show a solid growth, because of increased 3G and 4G device adoption. However, recent government...
There are some interesting developments about using Ethereum in the gaming space. Gods Unchained, the first competitive e-sports project on...
Gilead's tenofovir molecule formed the heart of the firm's $14 billion HIV franchise. Combo pills offer patients convenience and affordability, as...
JetBlue announced its plan to restructure operations and remove some positions through attrition, layoffs, and buyouts as part of a broad review...
The stock price surge was driven by Coherus Bio's European application for Neulasta biosimilar, which is now under review.
[IMG] Coherus BioSciences, Inc. Stock Compare Tool | Stock Guides Healthcare | Biotechnology | USA Coherus BioSciences, Inc., a biosimilar...
Last week, Rosenblatt initiated coverage of AAOI at Sell amid worries of price wars and declining margins. Even with demand up for fiberoptics in...
